 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || (R)-ketamine nasal spray (HS-10345) / Jiangsu Hansoh Pharma
Trial completion: A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression (clinicaltrials.gov) - Mar 9, 2023
P1, N=12, Completed, Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Active, not recruiting --> Completed
- || (R)-ketamine nasal spray (HS-10345) / Jiangsu Hansoh Pharma
Enrollment closed, Enrollment change, Trial completion date: A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression (clinicaltrials.gov) - Jun 15, 2022
P1, N=12, Active, not recruiting, Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=24 --> 12 | Trial completion date: Apr 2022 --> Jul 2022
- || (R)-ketamine nasal spray (HS-10345) / Jiangsu Hansoh Pharma
New P1 trial: A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression (clinicaltrials.gov) - Jan 19, 2022
P1, N=24, Recruiting, Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.